Simultaneous Interrogation of Cancer Omics to Identify Subtypes With Significant Clinical Differences
Recent advances in high-throughput sequencing have accelerated the accumulation of omics data on the same tumor tissue from multiple sources. Intensive study of multi-omics integration on tumor samples can stimulate progress in precision medicine and is promising in detecting potential biomarkers. H...
Main Authors: | Aodan Xu, Jiazhou Chen, Hong Peng, GuoQiang Han, Hongmin Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2019.00236/full |
Similar Items
-
Omics Analysis of Educated Platelets in Cancer and Benign Disease of the Pancreas
by: Giulia Mantini, et al.
Published: (2021-12-01) -
Network-Based Integration of Multi-Omics Data Identifies the Determinants of miR-491-5p Effects
by: Matthieu Meryet-Figuiere, et al.
Published: (2021-08-01) -
Multi-Omics Analysis Reveals Novel Subtypes and Driver Genes in Glioblastoma
by: Yang Yuan, et al.
Published: (2020-11-01) -
Multi-omics profiling reveals microRNA-mediated insulin signaling networks
by: Yang-Chi-Dung Lin, et al.
Published: (2020-09-01) -
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer
by: Miriam Ragle Aure, et al.
Published: (2021-04-01)